Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

http://www.wikidata.org/entity/Q34265995

about

Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma.Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer.The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma.Increased Expression of FGF19 Contributes to Tumor Progression and Cell Motility of Human Thyroid Cancer.Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma.Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype.Anguilla japonica lectin 1 delivery through adenovirus vector induces apoptotic cancer cell death through interaction with PRMT5.Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.The emerging role of galectins in high-fatality cancers.Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells.Clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies

P2860

Q26784412-7940AA66-F940-457C-BB00-E7563051D420 Q33617469-BB51C4C3-3DFC-4BC7-8303-D5A07843571F Q33899239-A08BF85A-0AD9-4D34-BA5E-F3E66639F05C Q36763534-3A3AE383-43D9-416B-AF1A-5CF652CA53E8 Q37729026-A097CBAA-33CD-4153-8032-B910789D1B82 Q38744673-F5E89D15-7A82-4EAD-9D12-34B666435ADB Q39852179-8CB6FAAE-2225-453F-9F60-CF83C6551C2F Q40450069-B7AFA60F-E0DD-45BF-928F-F1384B0CC36D Q40979079-9038CBF5-2E2A-44F0-BA11-C8997FBA4127 Q43526905-83DC7CE7-129F-4730-B2B4-F1386C61418F Q45884221-BD14D065-3CA5-47BD-8AE7-517116F50561 Q46209871-6031179F-4ADE-486A-A903-257057FEF904 Q47329197-22E51DE0-58B6-4168-864C-C4ECA67C30A5 Q48553032-51CC8E0A-7995-4285-A6DC-86281BD3340A Q50101341-0CC5F63D-495D-4818-877D-41AE35BAB1B8 Q51122167-B15D7287-1370-4185-8ACC-44BD248916C4 Q53284113-B0F38A94-6F3A-4F5C-91E0-5C335FACCEA8 Q54697325-061814D9-8D72-4EAE-A7BF-F601F00AEF9F Q57491296-02B80CA2-D0CD-4C5E-872E-5940B7EAE8CD Q58613788-A05A0DD7-A9C3-47B0-BD0C-E181BD28DE5C

P2860

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

http://www.wikidata.org/entity/Q34265995

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@ast

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@en

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@nl

type

label

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@ast

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@en

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@nl

prefLabel

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@ast

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@en

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@nl

P1433

Q34265995-04CD4A36-C8F5-4A05-BD11-2302CAB4D751

P1476

Q34265995-3CCE0AB3-0471-4890-956C-C2AA7B15F5FD

P2093

Q34265995-13EDABEA-F63E-4E66-AFE5-CCEF830AA833

Q34265995-3C3FA84C-269C-4A9B-8C10-B37BBECA5DFD

Q34265995-4AF1E287-DD69-4ED4-A86A-FD0375A5FB83

Q34265995-747920A8-95D7-4AAE-8AEA-15E7277C209A

Q34265995-8E09BFE6-E166-46C7-87C0-76596AABD24D

Q34265995-8FE85388-FA49-4BAB-BB11-4823226C3B5A

Q34265995-96C1EBE9-9C4E-4EB3-B1AC-463B320D20F9

Q34265995-97A29978-8379-4D92-A8B5-EB5C6FC8E75D

Q34265995-B7F5C337-73BA-4DD8-BB0C-29E11637CA02

Q34265995-D3615960-2D92-4984-8649-4BAEB6EDDB6F

P2860

Q34265995-139245A4-7416-48C9-914A-1A7638FCD74E

Q34265995-191018BF-0C44-4CDA-B7DC-B8EDC9FFCDC5

Q34265995-20AAFDCD-72AD-4F1E-97D4-0E2D17A01CFA

Q34265995-21C9351B-C3CB-4DC2-AACB-0FC0572287C7

Q34265995-2787AD44-FE45-41CE-B355-35D7A913DD2A

Q34265995-331BE7DC-3075-405B-B284-560AF94BD89A

Q34265995-3BEF1DE2-DBDF-419D-B77C-25FB8AB7A5A0

Q34265995-3CBB71D5-F600-472B-B562-99D48802E78B

Q34265995-460D27CC-9CB6-47AB-B582-82DA175411FA

Q34265995-4B50A31A-6A5D-45D1-A2FD-1DF5EF1EEAA7

P2888

Q34265995-AFF54379-F7D7-4B14-8E96-2F5844F0B93E

P304

Q34265995-8D4361BE-EDB0-4205-AE74-7420C1860535

P31

Q34265995-300DF211-3964-4591-ABEE-3119343BC4B5

P356

Q34265995-75FF3D33-6A8C-4CF4-B448-894B5878FCCB

P478

Q34265995-5DF4FC04-BBCA-4197-A469-DFFE00294CAC

P50

Q34265995-68228DCD-E9B3-40CF-9F19-FE3AE9B7D46F

P577

Q34265995-14271F3E-6197-4004-B9C0-8A770847E0AD

P5875

Q34265995-4FDCEA07-BEC7-4D3E-A01F-4E4BF3985569

P698

Q34265995-22C5F0E1-AA5F-46F9-87D3-0DF18D8A6215

P932

Q34265995-2C2C7CA0-73B9-42CA-819F-9B4A2732F6F0

P356

S12967-014-0273-3

P1433

Journal of Translational Medicine

P1476

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

@en

P2093

De-Sheng Weng

http://www.w3.org/2001/XMLSchema#string

Jia He

http://www.w3.org/2001/XMLSchema#string

Jian-Chuan Xia

http://www.w3.org/2001/XMLSchema#string

Jian-Jun Li

http://www.w3.org/2001/XMLSchema#string

Jing-Jing Zhao

http://www.w3.org/2001/XMLSchema#string

Ke Pan

http://www.w3.org/2001/XMLSchema#string

Lin Lv

http://www.w3.org/2001/XMLSchema#string

Qi-Jing Wang

http://www.w3.org/2001/XMLSchema#string

Qiu-Zhong Pan

http://www.w3.org/2001/XMLSchema#string

Shan-Shan Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB

Galectins. Structure and function of a large family of animal lectins

Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Epidemiology of primary liver cancer.

Diagnostic utility of galectin-3 in thyroid cancer.

Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).

Hepatocellular carcinoma: the need for progress.

Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies.

P2888

s12967-014-0273-3

P304

273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-014-0273-3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266247160

http://www.w3.org/2001/XMLSchema#string

P698

25260879

http://www.w3.org/2001/XMLSchema#string

P932

4179848

http://www.w3.org/2001/XMLSchema#string